Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment

Authors :: Xiaoning Wang
Jiashuo Guo
Yan Liu
Na Zheng
Shaohan Xu
Lianhui Wu
Ruirui Yuan
Liying Xue
Jie Li
Source :: Frontiers in Medicine, Vol 11 (2024)
Publication Year :: 2024
Publisher :: Frontiers Media S.A., 2024.
Abstract: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare hematological malignancy with a highly aggressive behavior and median survival of

Subjects :: blastic plasmacytoid dendritic cell neoplasm
BCL2 inhibitor
venetoclax
hypomethylating agent
azacitidine
combination therapy
Medicine (General)
R5-920

Full Text Access

Tools